To validate the expression of 5xHRE/GFP as a marker of BxPC3 tumor cell hypoxia in vivo, we performed immunofluorescence staining on 10 individual BxPC3 tumor samples to correlate GFP expression with conventional markers of tumor hypoxia (i.e., PIMO and CA9). This evidence concerns the gene CA9 and neoplasm.